Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q60675238
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000332.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q60675238
|
035
|
|
|
‡a
(OCoLC)Q60675238
|
043
|
|
|
‡c
US
|
046
|
|
|
‡f
19430102
‡g
20120000
|
100
|
0 |
|
‡a
R. Edward Coleman
‡9
en
‡9
nl
‡9
ast
‡9
de
‡9
sk
‡9
sl
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
R. Edward Coleman
‡c
Narozen 2.1.1943. MD. Prof. Zabývá se nukleární medicínou. Publikace o zobrazovacích metodách v medicíně.
‡9
cs
|
670
|
|
|
‡a
Author's 123I-labeled soluble fibrin: preparation and comparison with other thrombus imaging agents
|
670
|
|
|
‡a
Author's (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis.
|
670
|
|
|
‡a
Author's 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery
|
670
|
|
|
‡a
Author's [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia
|
670
|
|
|
‡a
Author's [18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma
|
670
|
|
|
‡a
Author's 27. PET Image Interpretation. Attenuation-Corrected
|
670
|
|
|
‡a
Author's 27. PET Image Interpretation. Attenuation-Corrected (ATN) Vs Non-Attenuation Corrected (NATN) Images
|
670
|
|
|
‡a
Author's 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging
|
670
|
|
|
‡a
Author's 9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine
|
670
|
|
|
‡a
Author's 9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent
|
670
|
|
|
‡a
Author's A 3D model of non-uniform attenuation and detector response for efficient iterative reconstruction in SPECT.
|
670
|
|
|
‡a
Author's A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer
|
670
|
|
|
‡a
Author's A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium
|
670
|
|
|
‡a
Author's A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules
|
670
|
|
|
‡a
Author's A cone beam SPECT reconstruction algorithm with a displaced center of rotation.
|
670
|
|
|
‡a
Author's A filtered backprojection algorithm for axial head motion correction in fan-beam SPECT.
|
670
|
|
|
‡a
Author's A filtered-backprojection algorithm for fan-beam SPECT which corrects for patient motion.
|
670
|
|
|
‡a
Author's A filtered backprojection algorithm for pinhole SPECT with a displaced centre of rotation
|
670
|
|
|
‡a
Author's A new composite model of objects for Monte Carlo simulation of radiological imaging.
|
670
|
|
|
‡a
Author's A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
|
670
|
|
|
‡a
Author's A quantitative comparison of attenuation-weighted backprojection with multiplicative and iterative postprocessing attenuation compensation in SPECT
|
670
|
|
|
‡a
Author's A tabulated summary of the FDG PET literature.
|
670
|
|
|
‡a
Author's Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise
|
670
|
|
|
‡a
Author's Accuracy of positron emission tomography in identifying hilar
|
670
|
|
|
‡a
Author's Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
|
670
|
|
|
‡a
Author's Accuracy of registration of PET, SPECT and MR images of a brain phantom.
|
670
|
|
|
‡a
Author's Accuracy of surface fit registration for PET and MR brain images using full and incomplete brain surfaces.
|
670
|
|
|
‡a
Author's Acute pulmonary embolism: artificial neural network approach for diagnosis.
|
670
|
|
|
‡a
Author's Acute pulmonary embolism: cost-effectiveness analysis of the effect of artificial neural networks on patient care.
|
670
|
|
|
‡a
Author's Adult age differences in regional cerebral blood flow during visual world identification: evidence from H215O PET.
|
670
|
|
|
‡a
Author's Adult age differences in the functional neuroanatomy of verbal recognition memory
|
670
|
|
|
‡a
Author's Adult age differences in visual word identification: functional neuroanatomy by positron emission tomography
|
670
|
|
|
‡a
Author's Aging and attentional guidance during visual search: functional neuroanatomy by positron emission tomography
|
670
|
|
|
‡a
Author's Aging and recognition memory: changes in regional cerebral blood flow associated with components of reaction time distributions
|
670
|
|
|
‡a
Author's Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study
|
670
|
|
|
‡a
Author's An artificial neural network approach to quantitative single photon emission computed tomographic reconstruction with collimator, attenuation, and scatter compensation
|
670
|
|
|
‡a
Author's An evaluation of lesion detectability with cone-beam, fanbeam and parallel-beam collimation in SPECT by continuous ROC study.
|
670
|
|
|
‡a
Author's An in vivo evaluation of I-fibrinogen labeled by four different methods
|
670
|
|
|
‡a
Author's An interactive, computer-based atlas of neurologic positron emission tomographic studies for use in teaching
|
670
|
|
|
‡a
Author's An ischemic index from the electrocardiogram to select patients with low left ventricular ejection fraction for coronary artery bypass grafting
|
670
|
|
|
‡a
Author's An overview of a camera-based SPECT system
|
670
|
|
|
‡a
Author's Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
|
670
|
|
|
‡a
Author's Approximate 3D iterative reconstruction for SPECT
|
670
|
|
|
‡a
Author's Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
|
670
|
|
|
‡a
Author's Artificial neural network for diagnosis of acute pulmonary embolism: effect of case and observer selection.
|
670
|
|
|
‡a
Author's Assessment of left ventricular function by resting and exercise radionuclide angiocardiography following acute myocardial infarction
|
670
|
|
|
‡a
Author's Assessment of regional left ventricular function using gated radionuclide angiography
|
670
|
|
|
‡a
Author's Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans
|
670
|
|
|
‡a
Author's Association of physical fitness and transient myocardial ischemia in patients with coronary artery disease
|
670
|
|
|
‡a
Author's Bayesian reconstruction and use of anatomical a priori information for emission tomography
|
670
|
|
|
‡a
Author's Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study
|
670
|
|
|
‡a
Author's Brain phantom: high-resolution imaging with SPECT and I-123
|
670
|
|
|
‡a
Author's Breast tumour imaging using incomplete circular orbit pinhole SPET: a phantom study
|
670
|
|
|
‡a
Author's Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
|
670
|
|
|
‡a
Author's Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models.
|
670
|
|
|
‡a
Author's Carcinoid tumors: iodine-131 MIBG scintigraphy
|
670
|
|
|
‡a
Author's Cardiac ejection fraction: phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography
|
670
|
|
|
‡a
Author's Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images
|
670
|
|
|
‡a
Author's Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women
|
670
|
|
|
‡a
Author's Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT.
|
670
|
|
|
‡a
Author's Cerebellar activity and disturbed time sense after THC.
|
670
|
|
|
‡a
Author's Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography.
|
670
|
|
|
‡a
Author's Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
|
670
|
|
|
‡a
Author's Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease.
|
670
|
|
|
‡a
Author's Chronic CSF leak into the peritoneal cavity shown by radionuclide cisternography. Successful treatment with an epidural blood patch.
|
670
|
|
|
‡a
Author's Chronic stable angina monotherapy. Nifedipine versus propranolol
|
670
|
|
|
‡a
Author's Cisternographic imaging patterns: effects of partial extra-arachnoid radiopharmaceutical injection and postinjection CSF leakage
|
670
|
|
|
‡a
Author's Clinical application of PET for the evaluation of brain tumors
|
670
|
|
|
‡a
Author's Clinical applications of PET in oncology
|
670
|
|
|
‡a
Author's Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
|
670
|
|
|
‡a
Author's Clinical oncologic positron emission tomography: an introduction
|
670
|
|
|
‡a
Author's Clinical positron emission tomography imaging
|
670
|
|
|
‡a
Author's Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence
|
670
|
|
|
‡a
Author's Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
|
670
|
|
|
‡a
Author's Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms
|
670
|
|
|
‡a
Author's Combination of converging collimators for high-sensitivity brain SPECT.
|
670
|
|
|
‡a
Author's Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease
|
670
|
|
|
‡a
Author's Combined Tc-99m sestamibi first-pass radionuclide angiography and cardiac SPECT imaging during arbutamine infusion delivered by a computerized closed-loop system
|
670
|
|
|
‡a
Author's Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats
|
670
|
|
|
‡a
Author's Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
|
670
|
|
|
‡a
Author's Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication
|
670
|
|
|
‡a
Author's Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia
|
670
|
|
|
‡a
Author's Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise
|
670
|
|
|
‡a
Author's Computed tomography in the evaluation of thyroid disease
|
670
|
|
|
‡a
Author's Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
|
670
|
|
|
‡a
Author's Cone beam collimation for single photon emission computed tomography: analysis, simulation, and image reconstruction using filtered backprojection.
|
670
|
|
|
‡a
Author's Convergence of the maximum likelihood reconstruction algorithm for emission computed tomography.
|
670
|
|
|
‡a
Author's Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy
|
670
|
|
|
‡a
Author's Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
|
670
|
|
|
‡a
Author's Deconvolution of Compton scatter in SPECT.
|
670
|
|
|
‡a
Author's Deep venous thrombosis: experience with gradient-echo MR imaging in 66 patients
|
670
|
|
|
‡a
Author's Depression and increased myocardial ischemic activity in patients with ischemic heart disease.
|
670
|
|
|
‡a
Author's Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography
|
670
|
|
|
‡a
Author's Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
|
670
|
|
|
‡a
Author's Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience
|
670
|
|
|
‡a
Author's Detection of pulmonary emboli in dogs: comparison of single photon emission computed tomography, gamma camera imaging, and angiography
|
670
|
|
|
‡a
Author's Determinants of variable exercise performance among patients with severe left ventricular dysfunction.
|
670
|
|
|
‡a
Author's Determination of both mechanical and electronic shifts in cone beam SPECT.
|
670
|
|
|
‡a
Author's Diagnosis of pancreatic carcinoma: role of FDG PET
|
670
|
|
|
‡a
Author's Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS
|
670
|
|
|
‡a
Author's Direct cone beam SPECT reconstruction with camera tilt
|
670
|
|
|
‡a
Author's Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes
|
670
|
|
|
‡a
Author's Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma
|
670
|
|
|
‡a
Author's Distribution of 99Tcm-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation
|
670
|
|
|
‡a
Author's Does the preparation and utilization of 99mTc-sulfur colloid affect the outcomes of breast lymphoscintigraphy?
|
670
|
|
|
‡a
Author's Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
|
670
|
|
|
‡a
Author's Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
|
670
|
|
|
‡a
Author's Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
|
670
|
|
|
‡a
Author's Dynamic contrast-enhanced MR imaging assessment of vascularized free fibular grafts
|
670
|
|
|
‡a
Author's Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
|
670
|
|
|
‡a
Author's Effect of age on the response of the left ventricular ejection fraction to exercise
|
670
|
|
|
‡a
Author's Effect of iodination level on the properties of radioiodinated fibrinogen.
|
670
|
|
|
‡a
Author's Effect of partial decreases in exercise work load on radionuclide indexes of ischemia
|
670
|
|
|
‡a
Author's Effect of rate-dependent left bundle branch block on global and regional left ventricular function
|
670
|
|
|
‡a
Author's Effect of region assignment on relative renal blood flow estimates using radionuclides
|
670
|
|
|
‡a
Author's Effect of registration errors between transmission and emission scans on a SPECT system using sequential scanning.
|
670
|
|
|
‡a
Author's Effects of characteristic x-rays on assay of I-123 by dose calibrator
|
670
|
|
|
‡a
Author's Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial
|
670
|
|
|
‡a
Author's Effects of Exercise Training on Bone Density in Older Men and Women
|
670
|
|
|
‡a
Author's Effects of exercise training on cardiorespiratory function in men and women older than 60 years of age.
|
670
|
|
|
‡a
Author's Effects of exercise training on ventricular function in patients with recent myocardial infarction
|
670
|
|
|
‡a
Author's Effects of physical conditioning on left ventricular ejection fraction in patients with coronary artery disease
|
670
|
|
|
‡a
Author's Effects of specific activity on meta-[
|
670
|
|
|
‡a
Author's Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart
|
670
|
|
|
‡a
Author's Efficacy of skull imaging in routine bone scanning.
|
670
|
|
|
‡a
Author's Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies
|
670
|
|
|
‡a
Author's Ejection fraction response to exercise in patients with chest pain, coronary artery disease and normal resting ventricular function
|
670
|
|
|
‡a
Author's Emotional responsivity and transient myocardial ischemia
|
670
|
|
|
‡a
Author's Energy and spatial distribution of multiple order Compton scatter in SPECT: a Monte Carlo investigation
|
670
|
|
|
‡a
Author's Esophageal source measurement of Tc-99m attenuation coefficients for use in left ventricular volume determinations
|
670
|
|
|
‡a
Author's Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography
|
670
|
|
|
‡a
Author's Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography
|
670
|
|
|
‡a
Author's Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET
|
670
|
|
|
‡a
Author's Evaluation of primary pulmonary carcinoid tumors using FDG PET
|
670
|
|
|
‡a
Author's Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism.
|
670
|
|
|
‡a
Author's Evaluation of SPECT quantification of radiopharmaceutical distribution in canine myocardium.
|
670
|
|
|
‡a
Author's Exercise radionuclide angiocardiography predicts cardiac death in patients with coronary artery disease
|
670
|
|
|
‡a
Author's Experimentally measured scatter fractions and energy spectra as a test of Monte Carlo simulations
|
670
|
|
|
‡a
Author's Factors affecting ventricular volumes determined by a count-based equilibrium method.
|
670
|
|
|
‡a
Author's Fast transmission CT for determining attenuation maps using a collimated line source, rotatable air-copper-lead attenuators and fan-beam collimation
|
670
|
|
|
‡a
Author's FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET
|
670
|
|
|
‡a
Author's FDG PET imaging in patients with pathologically verified dementia.
|
670
|
|
|
‡a
Author's FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
|
670
|
|
|
‡a
Author's FDG-PET in Pediatric Posterior Fossa Brain Tumors
|
670
|
|
|
‡a
Author's FDG-PET in the selection of brain lesions for biopsy
|
670
|
|
|
‡a
Author's FDG PET of pleural effusions in patients with non-small cell lung cancer
|
670
|
|
|
‡a
Author's Fibrinogen uptake by thrombi: effect of thrombus age
|
670
|
|
|
‡a
Author's First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer
|
670
|
|
|
‡a
Author's Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model
|
670
|
|
|
‡a
Author's Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
|
670
|
|
|
‡a
Author's Fractal Texture Analysis of Perfusion Lung Scans
|
670
|
|
|
‡a
Author's Ga-67 uptake in the lung in sarcoidosis
|
670
|
|
|
‡a
Author's Gallium-68 labeled red cells and platelets: new agents for positron tomography
|
670
|
|
|
‡a
Author's Gangliogliomas: characterization by registered positron emission tomography-MR images.
|
670
|
|
|
‡a
Author's Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.
|
670
|
|
|
‡a
Author's Half-cone beam collimation for triple-camera SPECT systems.
|
670
|
|
|
‡a
Author's Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies
|
670
|
|
|
‡a
Author's Highly iodinated fibrinogen: a new thrombus-localizing agent
|
670
|
|
|
‡a
Author's Human herpesvirus 6 limbic encephalitis after stem cell transplantation
|
670
|
|
|
‡a
Author's Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy
|
670
|
|
|
‡a
Author's Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging
|
670
|
|
|
‡a
Author's Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography
|
670
|
|
|
‡a
Author's Image resampling on a cylindrical sector grid
|
670
|
|
|
‡a
Author's Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine.
|
670
|
|
|
‡a
Author's Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
|
670
|
|
|
‡a
Author's Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
|
670
|
|
|
‡a
Author's Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry
|
670
|
|
|
‡a
Author's Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies
|
670
|
|
|
‡a
Author's Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging
|
670
|
|
|
‡a
Author's Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry
|
670
|
|
|
‡a
Author's Impact of positron emission tomography/computed tomography and positron emission tomography
|
670
|
|
|
‡a
Author's Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry
|
670
|
|
|
‡a
Author's Implementation of an accelerated iterative algorithm for cone-beam SPECT.
|
670
|
|
|
‡a
Author's Improved noninvasive diagnosis of acute pulmonary embolism with optimally selected clinical and chest radiographic findings.
|
670
|
|
|
‡a
Author's Improved SPECT quantification using compensation for scattered photons.
|
670
|
|
|
‡a
Author's In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent
|
670
|
|
|
‡a
Author's In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies
|
670
|
|
|
‡a
Author's In vivo regional quantitation of intrathoracic Tc-99m using SPECT: concise communication
|
670
|
|
|
‡a
Author's Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma
|
670
|
|
|
‡a
Author's Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.
|
670
|
|
|
‡a
Author's Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease.
|
670
|
|
|
‡a
Author's Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin
|
670
|
|
|
‡a
Author's Instrumentation for single-photon-emission computed tomographic studies of the brain
|
670
|
|
|
‡a
Author's Interpretation variability of 18FDG-positron emission tomography studies in dementia.
|
670
|
|
|
‡a
Author's Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
|
670
|
|
|
‡a
Author's Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results
|
670
|
|
|
‡a
Author's Inverse Monte Carlo as a unified reconstruction algorithm for ECT.
|
670
|
|
|
‡a
Author's Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
|
670
|
|
|
‡a
Author's Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma
|
670
|
|
|
‡a
Author's Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma
|
670
|
|
|
‡a
Author's Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients
|
670
|
|
|
‡a
Author's Left ventricular functional assessment in mice: feasibility of high spatial and temporal resolution ECG-gated blood pool SPECT.
|
670
|
|
|
‡a
Author's Lesion detection with single-photon emission computed tomography
|
670
|
|
|
‡a
Author's Lesion detection with single-photon emission computed tomography (SPECT) compared with conventional imaging
|
670
|
|
|
‡a
Author's Letter: Preparation of 125 I-fibrinogen
|
670
|
|
|
‡a
Author's Lexical and sublexical components of age-related changes in neural activation during visual word identification
|
670
|
|
|
‡a
Author's Limbic encephalitis: comparison of FDG PET and MR imaging findings
|
670
|
|
|
‡a
Author's Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease
|
670
|
|
|
‡a
Author's Local recurrence of rectal cancer:evaluation with F-18 fluorodeoxyglucose PET imaging
|
670
|
|
|
‡a
Author's Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors
|
670
|
|
|
‡a
Author's Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise
|
670
|
|
|
‡a
Author's Long-term effects of exercise on psychological functioning in older men and women
|
670
|
|
|
‡a
Author's Lung scan interpretation: effect of different observers and different criteria
|
670
|
|
|
‡a
Author's Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
|
670
|
|
|
‡a
Author's Mammotomography with pinhole incomplete circular orbit SPECT.
|
670
|
|
|
‡a
Author's Marijuana intoxication and brain activation in marijuana smokers
|
670
|
|
|
‡a
Author's Maximum likelihood reconstruction for pinhole SPECT with a displaced center-of-rotation.
|
670
|
|
|
‡a
Author's Measuring astatine-211 distributions with SPECT
|
670
|
|
|
‡a
Author's Mechanism and significance of a decrease in ejection fraction during exercise in patients with coronary artery disease and left ventricular dysfunction at rest
|
670
|
|
|
‡a
Author's Medicare coverage of PET for cervical cancer
|
670
|
|
|
‡a
Author's Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features.
|
670
|
|
|
‡a
Author's Migration of human dendritic cells after injection in patients with metastatic malignancies
|
670
|
|
|
‡a
Author's Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET
|
670
|
|
|
‡a
Author's Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis
|
670
|
|
|
‡a
Author's Monte Carlo evaluation of Compton scatter subtraction in single photon emission computed tomography.
|
670
|
|
|
‡a
Author's MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study
|
670
|
|
|
‡a
Author's Multifractal texture analysis of perfusion lung scans as a potential diagnostic tool for acute pulmonary embolism.
|
670
|
|
|
‡a
Author's Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects
|
670
|
|
|
‡a
Author's Myocardial ischemia in constrictive pericarditis
|
670
|
|
|
‡a
Author's Myocardial perfusion and ventricular function measurements during total coronary artery occlusion in humans. A comparison with rest and exercise radionuclide studies
|
670
|
|
|
‡a
Author's NCCN task force: clinical utility of PET in a variety of tumor types
|
670
|
|
|
‡a
Author's NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
|
670
|
|
|
‡a
Author's Neuroimaging and early diagnosis of Alzheimer disease: a look to the future
|
670
|
|
|
‡a
Author's Neuroimaging in infantile autism
|
670
|
|
|
‡a
Author's Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates
|
670
|
|
|
‡a
Author's Noise characteristics for cone beam collimators: a comparison with parallel hole collimator.
|
670
|
|
|
‡a
Author's Nonisotropic attenuation in SPECT: phantom tests of quantitative effects and compensation techniques
|
670
|
|
|
‡a
Author's Normal brain F-18 FDG-PET and MRI anatomy.
|
670
|
|
|
‡a
Author's Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results
|
670
|
|
|
‡a
Author's Nuclear medicine in the new millennium.
|
670
|
|
|
‡a
Author's Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.
|
670
|
|
|
‡a
Author's Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi
|
670
|
|
|
‡a
Author's Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model
|
670
|
|
|
‡a
Author's Performance characteristics of a whole-body PET scanner
|
670
|
|
|
‡a
Author's Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers
|
670
|
|
|
‡a
Author's PET and brain tumor image fusion
|
670
|
|
|
‡a
Author's PET and PET/CT reports: observations from the National Oncologic PET Registry.
|
670
|
|
|
‡a
Author's PET evaluation of lung cancer
|
670
|
|
|
‡a
Author's PET studies of the influences of nicotine on neural systems in cigarette smokers
|
670
|
|
|
‡a
Author's Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.
|
670
|
|
|
‡a
Author's Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.
|
670
|
|
|
‡a
Author's Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
|
670
|
|
|
‡a
Author's Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F
|
670
|
|
|
‡a
Author's Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
|
670
|
|
|
‡a
Author's Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
|
670
|
|
|
‡a
Author's Phase II trial of murine
|
670
|
|
|
‡a
Author's Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
|
670
|
|
|
‡a
Author's Physical and biological predictors of changes in whole-lung function following thoracic irradiation
|
670
|
|
|
‡a
Author's Physical conditioning and left ventricular performance in the elderly: assessment by radionuclide angiocardiography
|
670
|
|
|
‡a
Author's Physiologic basis for the age-related decline in aerobic work capacity
|
670
|
|
|
‡a
Author's Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy
|
670
|
|
|
‡a
Author's Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT.
|
670
|
|
|
‡a
Author's Pitfalls in myocardial perfusion assessment with dynamic MR imaging after administration of a contrast material bolus in dogs
|
670
|
|
|
‡a
Author's Pixel driven implementation of filtered backprojection for reconstruction of fan beam SPECT data using a position dependent effective projection bin length
|
670
|
|
|
‡a
Author's Positron emission tomography: brain tumors and lung cancer
|
670
|
|
|
‡a
Author's Positron emission tomography imaging of brain tumors
|
670
|
|
|
‡a
Author's Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer
|
670
|
|
|
‡a
Author's Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol
|
670
|
|
|
‡a
Author's Practical approach to diagnostic CT combined with PET.
|
670
|
|
|
‡a
Author's Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers
|
670
|
|
|
‡a
Author's Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging.
|
670
|
|
|
‡a
Author's Prediction of myocardial perfusion abnormalities by quantitative regional function using a radionuclide angiography database: a comparison with wall motion analysis
|
670
|
|
|
‡a
Author's Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: a comparison with clinical and electrocardiographic data
|
670
|
|
|
‡a
Author's Preparation and use of 123I-labeled highly iodinated fibrinogen for imaging deep-vein thrombi
|
670
|
|
|
‡a
Author's Primary muscle lymphoma: clinical and imaging findings
|
670
|
|
|
‡a
Author's Procedure guideline for lung scintigraphy: 1.0. Society of Nuclear Medicine
|
670
|
|
|
‡a
Author's Procedure Guideline for SPECT/CT Imaging 1.0.
|
670
|
|
|
‡a
Author's Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
|
670
|
|
|
‡a
Author's Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease
|
670
|
|
|
‡a
Author's Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group
|
670
|
|
|
‡a
Author's Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease
|
670
|
|
|
‡a
Author's Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma
|
670
|
|
|
‡a
Author's Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables
|
670
|
|
|
‡a
Author's Prospective evaluation of radionuclide angiocardiography for the diagnosis of coronary artery disease
|
670
|
|
|
‡a
Author's Prospective investigation of positron emission tomography in lung nodules
|
670
|
|
|
‡a
Author's Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group
|
670
|
|
|
‡a
Author's ProstaScint
|
670
|
|
|
‡a
Author's ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology.
|
670
|
|
|
‡a
Author's Pulmonary abnormalities and PET data analysis: a retrospective study
|
670
|
|
|
‡a
Author's Quantification of myocardial perfusion by MRI after coronary occlusion
|
670
|
|
|
‡a
Author's Quantification of radiation-induced regional lung injury with perfusion imaging
|
670
|
|
|
‡a
Author's Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal models
|
670
|
|
|
‡a
Author's Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements
|
670
|
|
|
‡a
Author's Quantitative imaging of iodine-131 distributions in brain tumors with pinhole SPECT: a phantom study.
|
670
|
|
|
‡a
Author's Quantitative pulmonary single photon emission computed tomography for radiotherapy applications.
|
670
|
|
|
‡a
Author's Quantitative SPECT reconstruction of iodine-123 data
|
670
|
|
|
‡a
Author's Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints
|
670
|
|
|
‡a
Author's Radioiodinated plasminogen: an imaging agent for pre-existing thrombi
|
670
|
|
|
‡a
Author's Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog
|
670
|
|
|
‡a
Author's Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury
|
670
|
|
|
‡a
Author's Recommendations on the use of 18F-FDG PET in oncology
|
670
|
|
|
‡a
Author's Reconstruction of SPECT images using generalized matrix inverses
|
670
|
|
|
‡a
Author's Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse
|
670
|
|
|
‡a
Author's Regional brain activity correlates of nicotine dependence
|
670
|
|
|
‡a
Author's Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization
|
670
|
|
|
‡a
Author's Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration
|
670
|
|
|
‡a
Author's Regional dose response to pulmonary irradiation using a manual method
|
670
|
|
|
‡a
Author's Regulation of stroke volume during submaximal and maximal upright exercise in normal man
|
670
|
|
|
‡a
Author's Relating radiation-induced regional lung injury to changes in pulmonary function tests
|
670
|
|
|
‡a
Author's Relation between myocardial perfusion and left ventricular function following acute coronary occlusion: disproportionate effects of anterior vs. inferior ischemia
|
670
|
|
|
‡a
Author's Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry
|
670
|
|
|
‡a
Author's Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring
|
670
|
|
|
‡a
Author's Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
|
670
|
|
|
‡a
Author's Scatter detection in SPECT imaging: dependence on source depth, energy, and energy window
|
670
|
|
|
‡a
Author's Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy
|
670
|
|
|
‡a
Author's Selective and divided visual attention: age-related changes in regional cerebral blood flow measured by H2(15)O PET
|
670
|
|
|
‡a
Author's Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities
|
670
|
|
|
‡a
Author's Serial Evaluation of Increased Chest Wall F-18 Fluorodeoxyglucose (FDG) Uptake Following Radiation Therapy in Patients With Bronchogenic Carcinoma
|
670
|
|
|
‡a
Author's Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors
|
670
|
|
|
‡a
Author's Sex-related differences in the normal cardiac response to upright exercise
|
670
|
|
|
‡a
Author's Simultaneous compensation for attenuation, scatter and detector response for SPECT reconstruction in three dimensions
|
670
|
|
|
‡a
Author's Simultaneous reconstruction, segmentation, and edge enhancement of relatively piecewise continuous images with intensity-level information.
|
670
|
|
|
‡a
Author's Single-photon-emission computed tomographic imaging of glioma
|
670
|
|
|
‡a
Author's Single photon emission computed tomography and its application in the lung
|
670
|
|
|
‡a
Author's Single photon emission computed tomography in the canine lung
|
670
|
|
|
‡a
Author's Single photon emission computed tomography (SPECT). Part II: Clinical applications
|
670
|
|
|
‡a
Author's Single photon emission computed tomography (SPECT). Principles and instrumentation
|
670
|
|
|
‡a
Author's Small-animal PET: advent of a new era of PET research
|
670
|
|
|
‡a
Author's SNM practice guideline for lung scintigraphy 4.0.
|
670
|
|
|
‡a
Author's Solid geometry-based object model for Monte Carlo simulated emission and transmission tomographic imaging systems.
|
670
|
|
|
‡a
Author's Solutions to problems in dose calibrator assay of iodine-123
|
670
|
|
|
‡a
Author's Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies
|
670
|
|
|
‡a
Author's Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
|
670
|
|
|
‡a
Author's SPECT quantification of technetium-99m microspheres within the canine lung
|
670
|
|
|
‡a
Author's SPECT using a specially designed cone beam collimator
|
670
|
|
|
‡a
Author's Staging non-small cell lung cancer with whole-body PET.
|
670
|
|
|
‡a
Author's Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms
|
670
|
|
|
‡a
Author's Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography
|
670
|
|
|
‡a
Author's Studying regional brain function: a challenge for SPECT.
|
670
|
|
|
‡a
Author's Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study
|
670
|
|
|
‡a
Author's Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers
|
670
|
|
|
‡a
Author's Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
|
670
|
|
|
‡a
Author's Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction
|
670
|
|
|
‡a
Author's Tc-99m attenuation coefficients in water-filled phantoms determined with gamma cameras
|
670
|
|
|
‡a
Author's Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy
|
670
|
|
|
‡a
Author's The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands
|
670
|
|
|
‡a
Author's The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers
|
670
|
|
|
‡a
Author's The effect of patient-specific factors on radiation-induced regional lung injury.
|
670
|
|
|
‡a
Author's The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry
|
670
|
|
|
‡a
Author's The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.
|
670
|
|
|
‡a
Author's The impact of urinary excretion of (18)F-labeled choline analogs
|
670
|
|
|
‡a
Author's The National Oncologic PET Registry
|
670
|
|
|
‡a
Author's The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development
|
670
|
|
|
‡a
Author's The National Oncologic PET Registry (NOPR): design and analysis plan
|
670
|
|
|
‡a
Author's The potential of monoclonal antibodies as carriers of radiation and drugs for immunodetection and therapy of brain tumors.
|
670
|
|
|
‡a
Author's The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
|
670
|
|
|
‡a
Author's The radionuclide renogram as a predictor of relative renal blood flow
|
670
|
|
|
‡a
Author's The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests
|
670
|
|
|
‡a
Author's The role of three dimensional functional lung imaging in radiation treatment planning: The functional dose-volume histogram
|
670
|
|
|
‡a
Author's The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up
|
670
|
|
|
‡a
Author's The use of radionuclide angiography in the diagnosis of coronary artery disease--a logistic regression analysis
|
670
|
|
|
‡a
Author's The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation
|
670
|
|
|
‡a
Author's Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
|
670
|
|
|
‡a
Author's Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model
|
670
|
|
|
‡a
Author's Three-dimensional photon detection kernels and their application to SPECT reconstruction
|
670
|
|
|
‡a
Author's Three-dimensional SPECT reconstruction of combined cone beam and parallel beam data
|
670
|
|
|
‡a
Author's Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography
|
670
|
|
|
‡a
Author's Tomographic images of blood pool and perfusion in brain and heart
|
670
|
|
|
‡a
Author's Transaxial tomographic imaging of canine myocardium with 11C-palmitic acid.
|
670
|
|
|
‡a
Author's Transmission imaging for nonuniform attenuation correction using a three-headed SPECT camera.
|
670
|
|
|
‡a
Author's Transmission scanning system for a gamma camera coincidence scanner
|
670
|
|
|
‡a
Author's Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
|
670
|
|
|
‡a
Author's Truncation artifact reduction in transmission CT for improved SPECT attenuation compensation
|
670
|
|
|
‡a
Author's Uptake and retention kinetics of para-fluorine-18-fluorobenzylguanidine in isolated rat heart.
|
670
|
|
|
‡a
Author's Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data
|
670
|
|
|
‡a
Author's Utilization of lung scans by clinicians
|
670
|
|
|
‡a
Author's Value and limitation of biplane rest and exercise radionuclide angiography for assessing individual bypass grafts: a prospective study
|
670
|
|
|
‡a
Author's Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction
|
670
|
|
|
‡a
Author's Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions
|
670
|
|
|
‡a
Author's Ventilation-perfusion lung scintigraphy as a guide for pulmonary angiography in the localization of pulmonary emboli.
|
670
|
|
|
‡a
Author's Ventilation-perfusion scanning and pulmonary angiography: correlation in clinical high-probability pulmonary embolism
|
670
|
|
|
‡a
Author's Ventilation-perfusion scintigraphy in the PIOPED study. Part I. Data collection and tabulation.
|
670
|
|
|
‡a
Author's Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations
|
670
|
|
|
‡a
Author's Volume and activity quantitation with iodine-123 SPECT
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NII|DA12718741
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|136383297
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 0103001710
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000116332796
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NTA|111000556
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BIBSYS|2127530
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/45779180
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NKC|nlk20040151297
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|n 86040915
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|081785968
|
912
|
|
|
‡a
18fflorbetapirpositronemissiontomographydeterminedcerebralβamyloiddepositionandneurocognitiveperformanceaftercardiacsurgery
‡A
18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery
‡9
1
|
912
|
|
|
‡a
associationofcommongeneticvariantsingpcpd1withscalingofvisualcorticalsurfaceareainhumans
‡A
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans
‡9
1
|
919
|
|
|
‡a
quantitativeeffectsofcontrastenhancedctattenuationcorrectiononpetsuvmeasurements
‡A
Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements
‡9
1
|
919
|
|
|
‡a
quantitativeimagingofiodine131distributionsinbraintumorswithpinholespectaphantomstudy
‡A
Quantitative imaging of iodine-131 distributions in brain tumors with pinhole SPECT: a phantom study.
‡9
1
|
919
|
|
|
‡a
quantitativepulmonarysinglephotonemissioncomputedtomographyforradiotherapyapplications
‡A
Quantitative pulmonary single photon emission computed tomography for radiotherapy applications.
‡9
1
|
919
|
|
|
‡a
volumeandactivityquantitationwithiodine123spect
‡A
Volume and activity quantitation with iodine-123 SPECT
‡9
1
|
919
|
|
|
‡a
ventilationperfusionscintigraphyinthepiopedstudypart2evaluationofthescintigraphiccriteriaandinterpretations
‡A
Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations
‡9
1
|
919
|
|
|
‡a
ventilationperfusionscintigraphyinthepiopedstudypart1datacollectionandtabulation
‡A
Ventilation-perfusion scintigraphy in the PIOPED study. Part I. Data collection and tabulation.
‡9
1
|
919
|
|
|
‡a
ventilationperfusionscanningandpulmonaryangiographycorrelationinclinicalhighprobabilitypulmonaryembolism
‡A
Ventilation-perfusion scanning and pulmonary angiography: correlation in clinical high-probability pulmonary embolism
‡9
1
|
919
|
|
|
‡a
ventilationperfusionlungscintigraphyasaguideforpulmonaryangiographyinthelocalizationofpulmonaryemboli
‡A
Ventilation-perfusion lung scintigraphy as a guide for pulmonary angiography in the localization of pulmonary emboli.
‡9
1
|
919
|
|
|
‡a
variabletimepositronemissiontomographylegprotocoltoequalizenoiseforpositronemissiontomographycomputedtomographyacquisitions
‡A
Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions
‡9
1
|
919
|
|
|
‡a
valueofradionuclideangiographyforpredictingspecificcardiaceventsafteracutemyocardialinfarction
‡A
Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction
‡9
1
|
919
|
|
|
‡a
valueandlimitationofbiplanerestandexerciseradionuclideangiographyforassessingindividualbypassgraftsaprospectivestudy
‡A
Value and limitation of biplane rest and exercise radionuclide angiography for assessing individual bypass grafts: a prospective study
‡9
1
|
919
|
|
|
‡a
utilizationoflungscansbyclinicians
‡A
Utilization of lung scans by clinicians
‡9
1
|
919
|
|
|
‡a
usefulnessofserialradionuclideangiographyinpredictingcardiacdeathaftercoronaryarterybypassgraftingandcomparisonwithclinicalandcardiaccatheterizationdata
‡A
Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data
‡9
1
|
919
|
|
|
‡a
uptakeandretentionkineticsofparafluorine18fluorobenzylguanidineinisolatedratheart
‡A
Uptake and retention kinetics of para-fluorine-18-fluorobenzylguanidine in isolated rat heart.
‡9
1
|
919
|
|
|
‡a
truncationartifactreductionintransmissionctforimprovedspectattenuationcompensation
‡A
Truncation artifact reduction in transmission CT for improved SPECT attenuation compensation
‡9
1
|
919
|
|
|
‡a
treatmentofintracranialhumangliomaxenograftswith131ilabeledantitenascinmonoclonalantibody81c6
‡A
Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
‡9
1
|
919
|
|
|
‡a
transmissionscanningsystemforagammacameracoincidencescanner
‡A
Transmission scanning system for a gamma camera coincidence scanner
‡9
1
|
919
|
|
|
‡a
transmissionimagingfornonuniformattenuationcorrectionusinga3headedspectcamera
‡A
Transmission imaging for nonuniform attenuation correction using a three-headed SPECT camera.
‡9
1
|
919
|
|
|
‡a
transaxialtomographicimagingofcaninemyocardiumwith11cpalmiticacid
‡A
Transaxial tomographic imaging of canine myocardium with 11C-palmitic acid.
‡9
1
|
919
|
|
|
‡a
tomographicimagesofbloodpoolandperfusioninbrainandheart
‡A
Tomographic images of blood pool and perfusion in brain and heart
‡9
1
|
919
|
|
|
‡a
timecourseoftetrahydrocannabinolinducedchangesinregionalcerebralbloodflowmeasuredwithpositronemissiontomography
‡A
Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography
‡9
1
|
919
|
|
|
‡a
3dimensionalspectreconstructionofcombinedconebeamandparallelbeamdata
‡A
Three-dimensional SPECT reconstruction of combined cone beam and parallel beam data
‡9
1
|
919
|
|
|
‡a
3dimensionalphotondetectionkernelsandtheirapplicationtospectreconstruction
‡A
Three-dimensional photon detection kernels and their application to SPECT reconstruction
‡9
1
|
919
|
|
|
‡a
therapeuticefficacyofantigliomamesenchymalextracellularmatrix131iradiolabeledmurinemonoclonalantibodyinahumangliomaxenograftmodel
‡A
Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model
‡9
1
|
919
|
|
|
‡a
therapeuticangiogenesisinchronicallyischemicporcinemyocardiumcomparativeeffectsofbfgfandvegf
‡A
Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
‡9
1
|
919
|
|
|
‡a
utilityofspectlungperfusionscansinminimizingandassessingthephysiologicconsequencesofthoracicirradiation
‡A
The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation
‡9
1
|
919
|
|
|
‡a
useofradionuclideangiographyinthediagnosisofcoronaryarterydiseasealogisticregressionanalysis
‡A
The use of radionuclide angiography in the diagnosis of coronary artery disease--a logistic regression analysis
‡9
1
|
919
|
|
|
‡a
timecourseofradiationtherapyinducedreductionsinregionalperfusionaprospectivestudywith5yearsoffollowup
‡A
The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up
‡9
1
|
919
|
|
|
‡a
roleof3dimensionalfunctionallungimaginginradiationtreatmentplanningthefunctionaldosevolumehistogram
‡A
The role of three dimensional functional lung imaging in radiation treatment planning: The functional dose-volume histogram
‡9
1
|
919
|
|
|
‡a
roleoflungperfusionimaginginpredictingthedirectionofradiationinducedchangesinpulmonaryfunctiontests
‡A
The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests
‡9
1
|
919
|
|
|
‡a
radionucliderenogramasapredictorofrelativerenalbloodflow
‡A
The radionuclide renogram as a predictor of relative renal blood flow
‡9
1
|
919
|
|
|
‡a
prognosticsignificanceoffluorodeoxyglucosepositronemissiontomographyimagingforpatientswithnonsmallcelllungcarcinoma
‡A
The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
‡9
1
|
919
|
|
|
‡a
potentialofmonoclonalantibodiesascarriersofradiationanddrugsforimmunodetectionandtherapyofbraintumors
‡A
The potential of monoclonal antibodies as carriers of radiation and drugs for immunodetection and therapy of brain tumors.
‡9
1
|
919
|
|
|
‡a
nationaloncologicpetregistrynoprdesignandanalysisplan
‡A
The National Oncologic PET Registry (NOPR): design and analysis plan
‡9
1
|
919
|
|
|
‡a
nationaloncologicpetregistryexpandedmedicarecoverageforpetundercoveragewithevidencedevelopment
‡A
The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development
‡9
1
|
919
|
|
|
‡a
nationaloncologicpetregistry
‡A
The National Oncologic PET Registry
‡9
1
|
919
|
|
|
‡a
impactofurinaryexcretionof18flabeledcholineanalogs
‡A
The impact of urinary excretion of (18)F-labeled choline analogs
‡9
1
|
919
|
|
|
‡a
impactofradiationtherapyinpatientswithdiffuselargebcelllymphomawithpositivepostchemotherapyfdgpetorgallium67scans
‡A
The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.
‡9
1
|
919
|
|
|
‡a
impactofpositronemissiontomographypetonexpectedmanagementduringcancertreatmentfindingsofthenationaloncologicpetregistry
‡A
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry
‡9
1
|
919
|
|
|
‡a
effectofpatientspecificfactorsonradiationinducedregionallunginjury
‡A
The effect of patient-specific factors on radiation-induced regional lung injury.
‡9
1
|
919
|
|
|
‡a
effectofmetabolicmilieuoncardiacpetimagingusingfluorine18deoxyglucoseandnitrogen13ammoniainnormalvolunteers
‡A
The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers
‡9
1
|
919
|
|
|
‡a
complementaryrolesoffastspinechomrimaginganddoublephase99mtcsestamibiscintigraphyforlocalizationofhyperfunctioningparathyroidglands
‡A
The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands
‡9
1
|
919
|
|
|
‡a
temporallobehypometabolismonpetpredictorofseizurecontrolaftertemporallobectomy
‡A
Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy
‡9
1
|
919
|
|
|
‡a
tc99mattenuationcoefficientsinwaterfilledphantomsdeterminedwithgammacameras
‡A
Tc-99m attenuation coefficients in water-filled phantoms determined with gamma cameras
‡9
1
|
919
|
|
|
‡a
tachycardiainducedcardiomyopathyareversibleformofleftventriculardysfunction
‡A
Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction
‡9
1
|
919
|
|
|
‡a
synthesisandevaluationof18flabeledcholineasanoncologictracerforpositronemissiontomographyinitialfindingsinprostatecancer
‡A
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
‡9
1
|
919
|
|
|
‡a
synthesisandevaluationof18flabeledcholineanalogsasoncologicpettracers
‡A
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers
‡9
1
|
919
|
|
|
‡a
sustainedradiographicandclinicalresponseinpatientwithbifrontalrecurrentglioblastomamultiformewithintracerebralinfusionoftherecombinanttargetedtoxintp38casestudy
‡A
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study
‡9
1
|
919
|
|
|
‡a
studyingregionalbrainfunctionachallengeforspect
‡A
Studying regional brain function: a challenge for SPECT.
‡9
1
|
919
|
|
|
‡a
studiesofprimarycentralnervoussystemlymphomawithfluorine18fluorodeoxyglucosepositronemissiontomography
‡A
Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography
‡9
1
|
919
|
|
|
‡a
stressmanagementandexercisetrainingincardiacpatientswithmyocardialischemiaeffectsonprognosisandevaluationofmechanisms
‡A
Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms
‡9
1
|
919
|
|
|
‡a
stagingnonsmallcelllungcancerwithwholebodypet
‡A
Staging non-small cell lung cancer with whole-body PET.
‡9
1
|
919
|
|
|
‡a
spectusingaspeciallydesignedconebeamcollimator
‡A
SPECT using a specially designed cone beam collimator
‡9
1
|
919
|
|
|
‡a
spectquantificationoftechnetium99mmicrosphereswithinthecaninelung
‡A
SPECT quantification of technetium-99m microspheres within the canine lung
‡9
1
|
919
|
|
|
‡a
specificimagingofhumanbraintumorxenograftsutilizingradiolabelledmonoclonalantibodiesmabs
‡A
Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
‡9
1
|
919
|
|
|
‡a
specificimagingofhumanbraintumorxenograftsutilizingradiolabelledmonoclonalantibodies
‡A
Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies
‡9
1
|
919
|
|
|
‡a
solutionstoproblemsindosecalibratorassayofiodine123
‡A
Solutions to problems in dose calibrator assay of iodine-123
‡9
1
|
919
|
|
|
‡a
solidgeometrybasedobjectmodelformontecarlosimulatedemissionandtransmissiontomographicimagingsystems
‡A
Solid geometry-based object model for Monte Carlo simulated emission and transmission tomographic imaging systems.
‡9
1
|
919
|
|
|
‡a
snmpracticeguidelineforlungscintigraphy40
‡A
SNM practice guideline for lung scintigraphy 4.0.
‡9
1
|
919
|
|
|
‡a
smallanimalpetadventofaneweraofpetresearch
‡A
Small-animal PET: advent of a new era of PET research
‡9
1
|
919
|
|
|
‡a
singlephotonemissioncomputedtomographyspectprinciplesandinstrumentation
‡A
Single photon emission computed tomography (SPECT). Principles and instrumentation
‡9
1
|
919
|
|
|
‡a
singlephotonemissioncomputedtomographyspectpart2clinicalapplications
‡A
Single photon emission computed tomography (SPECT). Part II: Clinical applications
‡9
1
|
919
|
|
|
‡a
singlephotonemissioncomputedtomographyinthecaninelung
‡A
Single photon emission computed tomography in the canine lung
‡9
1
|
919
|
|
|
‡a
singlephotonemissioncomputedtomographyanditsapplicationinthelung
‡A
Single photon emission computed tomography and its application in the lung
‡9
1
|
919
|
|
|
‡a
singlephotonemissioncomputedtomographicimagingofglioma
‡A
Single-photon-emission computed tomographic imaging of glioma
‡9
1
|
919
|
|
|
‡a
simultaneousreconstructionsegmentationandedgeenhancementofrelativelypiecewisecontinuousimageswithintensitylevelinformation
‡A
Simultaneous reconstruction, segmentation, and edge enhancement of relatively piecewise continuous images with intensity-level information.
‡9
1
|
919
|
|
|
‡a
simultaneouscompensationforattenuationscatteranddetectorresponseforspectreconstructionin3dimensions
‡A
Simultaneous compensation for attenuation, scatter and detector response for SPECT reconstruction in three dimensions
‡9
1
|
919
|
|
|
‡a
sexrelateddifferencesinthenormalcardiacresponsetouprightexercise
‡A
Sex-related differences in the normal cardiac response to upright exercise
‡9
1
|
919
|
|
|
‡a
serialfdgpetstudiesinthepredictionofsurvivalinpatientswithprimarybraintumors
‡A
Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors
‡9
1
|
919
|
|
|
‡a
serialevaluationofincreasedchestwallf18fluorodeoxyglucosefdguptakefollowingradiationtherapyinpatientswithbronchogeniccarcinoma
‡A
Serial Evaluation of Increased Chest Wall F-18 Fluorodeoxyglucose (FDG) Uptake Following Radiation Therapy in Patients With Bronchogenic Carcinoma
‡9
1
|
919
|
|
|
‡a
semiquantitativeandvisualanalysisoffdgpetimagesinpulmonaryabnormalities
‡A
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities
‡9
1
|
919
|
|
|
‡a
123ilabeledsolublefibrinpreparationandcomparisonwithotherthrombusimagingagents
‡A
123I-labeled soluble fibrin: preparation and comparison with other thrombus imaging agents
‡9
1
|
919
|
|
|
‡a
18ffluorodeoxyglucosepositronemissiontomographyandmrimagingfindingsinrasmussenencephalitis
‡A
(18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis.
‡9
1
|
919
|
|
|
‡a
2fluoro2deoxyglucosepositronemissiontomographycorrelationofgadoliniumenhancedmrimagingofcentralnervoussystemneoplasia
‡A
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia
‡9
1
|
919
|
|
|
‡a
fluorodeoxyglucosepositronemissiontomographyinpatientswithmedulloblastoma
‡A
[18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma
‡9
1
|
919
|
|
|
‡a
27petimageinterpretationattenuationcorrected
‡A
27. PET Image Interpretation. Attenuation-Corrected
‡9
1
|
919
|
|
|
‡a
27petimageinterpretationattenuationcorrectedatnvsnonattenuationcorrectednatnimages
‡A
27. PET Image Interpretation. Attenuation-Corrected (ATN) Vs Non-Attenuation Corrected (NATN) Images
‡9
1
|
919
|
|
|
‡a
3deoxy3fluorothymidinepositronemissiontomographyinpatientswithrecurrentglioblastomamultiformecomparisonwithgddtpaenhancedmagneticresonanceimaging
‡A
3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging
‡9
1
|
919
|
|
|
‡a
930945preliminaryevaluationoff18fluorocholine
‡A
9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine
‡9
1
|
919
|
|
|
‡a
930945preliminaryevaluationoff18fluorocholinefchasapettumorimagingagent
‡A
9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent
‡9
1
|
919
|
|
|
‡a
3dmodelofnonuniformattenuationanddetectorresponseforefficientiterativereconstructioninspect
‡A
A 3D model of non-uniform attenuation and detector response for efficient iterative reconstruction in SPECT.
‡9
1
|
919
|
|
|
‡a
comparativeanalysisofpositronemissiontomographyandmediastinoscopyinstagingnonsmallcelllungcancer
‡A
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer
‡9
1
|
919
|
|
|
‡a
comparisonofmechanicalandlasertransmyocardialrevascularizationforinductionofangiogenesisandarteriogenesisinchronicallyischemicmyocardium
‡A
A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium
‡9
1
|
919
|
|
|
‡a
comparisonofthediagnosticaccuracyof18ffdgpetandctinthecharacterizationofsolitarypulmonarynodules
‡A
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules
‡9
1
|
919
|
|
|
‡a
conebeamspectreconstructionalgorithmwithadisplacedcenterofrotation
‡A
A cone beam SPECT reconstruction algorithm with a displaced center of rotation.
‡9
1
|
919
|
|
|
‡a
filteredbackprojectionalgorithmforaxialheadmotioncorrectioninfanbeamspect
‡A
A filtered backprojection algorithm for axial head motion correction in fan-beam SPECT.
‡9
1
|
919
|
|
|
‡a
filteredbackprojectionalgorithmforfanbeamspectwhichcorrectsforpatientmotion
‡A
A filtered-backprojection algorithm for fan-beam SPECT which corrects for patient motion.
‡9
1
|
919
|
|
|
‡a
filteredbackprojectionalgorithmforpinholespectwithadisplacedcentreofrotation
‡A
A filtered backprojection algorithm for pinhole SPECT with a displaced centre of rotation
‡9
1
|
919
|
|
|
‡a
newcompositemodelofobjectsformontecarlosimulationofradiologicalimaging
‡A
A new composite model of objects for Monte Carlo simulation of radiological imaging.
‡9
1
|
919
|
|
|
‡a
pilotstudy131iantitenascinmonoclonalantibody81c6todelivera44gyresectioncavityboost
‡A
A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
‡9
1
|
919
|
|
|
‡a
quantitativecomparisonofattenuationweightedbackprojectionwithmultiplicativeanditerativepostprocessingattenuationcompensationinspect
‡A
A quantitative comparison of attenuation-weighted backprojection with multiplicative and iterative postprocessing attenuation compensation in SPECT
‡9
1
|
919
|
|
|
‡a
tabulatedsummaryofthefdgpetliterature
‡A
A tabulated summary of the FDG PET literature.
‡9
1
|
919
|
|
|
‡a
accuracyofdiagnosisofcoronaryarterydiseasebyradionuclidemanagementofleftventricularfunctionduringrestandexercise
‡A
Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise
‡9
1
|
919
|
|
|
‡a
accuracyofpositronemissiontomographyinidentifyinghilar
‡A
Accuracy of positron emission tomography in identifying hilar
‡9
1
|
919
|
|
|
‡a
accuracyofpositronemissiontomographyinidentifyinghilarn1lymphnodeinvolvementinnonsmallcelllungcancerimplicationsforstereotacticbodyradiationtherapy
‡A
Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
‡9
1
|
919
|
|
|
‡a
accuracyofregistrationofpetspectandmrimagesofabrainphantom
‡A
Accuracy of registration of PET, SPECT and MR images of a brain phantom.
‡9
1
|
919
|
|
|
‡a
accuracyofsurfacefitregistrationforpetandmrbrainimagesusingfullandincompletebrainsurfaces
‡A
Accuracy of surface fit registration for PET and MR brain images using full and incomplete brain surfaces.
‡9
1
|
919
|
|
|
‡a
acutepulmonaryembolismartificialneuralnetworkapproachfordiagnosis
‡A
Acute pulmonary embolism: artificial neural network approach for diagnosis.
‡9
1
|
919
|
|
|
‡a
acutepulmonaryembolismcosteffectivenessanalysisoftheeffectofartificialneuralnetworksonpatientcare
‡A
Acute pulmonary embolism: cost-effectiveness analysis of the effect of artificial neural networks on patient care.
‡9
1
|
919
|
|
|
‡a
adultagedifferencesinregionalcerebralbloodflowduringvisualworldidentificationevidencefromh215opet
‡A
Adult age differences in regional cerebral blood flow during visual world identification: evidence from H215O PET.
‡9
1
|
919
|
|
|
‡a
adultagedifferencesinthefunctionalneuroanatomyofverbalrecognitionmemory
‡A
Adult age differences in the functional neuroanatomy of verbal recognition memory
‡9
1
|
919
|
|
|
‡a
adultagedifferencesinvisualwordidentificationfunctionalneuroanatomybypositronemissiontomography
‡A
Adult age differences in visual word identification: functional neuroanatomy by positron emission tomography
‡9
1
|
919
|
|
|
‡a
agingandattentionalguidanceduringvisualsearchfunctionalneuroanatomybypositronemissiontomography
‡A
Aging and attentional guidance during visual search: functional neuroanatomy by positron emission tomography
‡9
1
|
919
|
|
|
‡a
agingandrecognitionmemorychangesinregionalcerebralbloodflowassociatedwithcomponentsofreactiontimedistributions
‡A
Aging and recognition memory: changes in regional cerebral blood flow associated with components of reaction time distributions
‡9
1
|
919
|
|
|
‡a
amyloidβassessedbyflorbetapirf18petand18monthcognitivedeclineamulticenterstudy
‡A
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study
‡9
1
|
919
|
|
|
‡a
artificialneuralnetworkapproachtoquantitativesinglephotonemissioncomputedtomographicreconstructionwithcollimatorattenuationandscattercompensation
‡A
An artificial neural network approach to quantitative single photon emission computed tomographic reconstruction with collimator, attenuation, and scatter compensation
‡9
1
|
919
|
|
|
‡a
evaluationoflesiondetectabilitywithconebeamfanbeamandparallelbeamcollimationinspectbycontinuousrocstudy
‡A
An evaluation of lesion detectability with cone-beam, fanbeam and parallel-beam collimation in SPECT by continuous ROC study.
‡9
1
|
919
|
|
|
‡a
invivoevaluationof1fibrinogenlabeledby4differentmethods
‡A
An in vivo evaluation of I-fibrinogen labeled by four different methods
‡9
1
|
919
|
|
|
‡a
interactivecomputerbasedatlasofneurologicpositronemissiontomographicstudiesforuseinteaching
‡A
An interactive, computer-based atlas of neurologic positron emission tomographic studies for use in teaching
‡9
1
|
919
|
|
|
‡a
ischemicindexfromtheelectrocardiogramtoselectpatientswithlowleftventricularejectionfractionforcoronaryarterybypassgrafting
‡A
An ischemic index from the electrocardiogram to select patients with low left ventricular ejection fraction for coronary artery bypass grafting
‡9
1
|
919
|
|
|
‡a
overviewofacamerabasedspectsystem
‡A
An overview of a camera-based SPECT system
‡9
1
|
919
|
|
|
‡a
apolipoproteineε4andageeffectsonflorbetapirpositronemissiontomographyinhealthyagingandalzheimerdisease
‡A
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
‡9
1
|
919
|
|
|
‡a
approximate3diterativereconstructionforspect
‡A
Approximate 3D iterative reconstruction for SPECT
‡9
1
|
919
|
|
|
‡a
arediscordantpositronemissiontomographyandpathologicalassessmentsofthemediastinuminnonsmallcelllungcancersignificant
‡A
Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
‡9
1
|
919
|
|
|
‡a
artificialneuralnetworkfordiagnosisofacutepulmonaryembolismeffectofcaseandobserverselection
‡A
Artificial neural network for diagnosis of acute pulmonary embolism: effect of case and observer selection.
‡9
1
|
919
|
|
|
‡a
assessmentofleftventricularfunctionbyrestingandexerciseradionuclideangiocardiographyfollowingacutemyocardialinfarction
‡A
Assessment of left ventricular function by resting and exercise radionuclide angiocardiography following acute myocardial infarction
‡9
1
|
919
|
|
|
‡a
assessmentofregionalleftventricularfunctionusinggatedradionuclideangiography
‡A
Assessment of regional left ventricular function using gated radionuclide angiography
‡9
1
|
919
|
|
|
‡a
associationofphysicalfitnessandtransientmyocardialischemiainpatientswithcoronaryarterydisease
‡A
Association of physical fitness and transient myocardial ischemia in patients with coronary artery disease
‡9
1
|
919
|
|
|
‡a
bayesianreconstructionanduseofanatomicalaprioriinformationforemissiontomography
‡A
Bayesian reconstruction and use of anatomical a priori information for emission tomography
‡9
1
|
919
|
|
|
‡a
brainmorphologicalchangesandearlymarijuanauseamagneticresonanceandpositronemissiontomographystudy
‡A
Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study
‡9
1
|
919
|
|
|
‡a
brainphantomhighresolutionimagingwithspectand1123
‡A
Brain phantom: high-resolution imaging with SPECT and I-123
‡9
1
|
919
|
|
|
‡a
breasttumourimagingusingincompletecircularorbitpinholespetaphantomstudy
‡A
Breast tumour imaging using incomplete circular orbit pinhole SPET: a phantom study
‡9
1
|
919
|
|
|
‡a
canwepredictradiationinducedchangesinpulmonaryfunctionbasedonthesumofpredictedregionaldysfunction
‡A
Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
‡9
1
|
919
|
|
|
‡a
carbon11labeledmethylatedpolyamineanalogsuptakeinprostateandtumorinanimalmodels
‡A
Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models.
‡9
1
|
919
|
|
|
‡a
carcinoidtumorsiodine131mibgscintigraphy
‡A
Carcinoid tumors: iodine-131 MIBG scintigraphy
‡9
1
|
919
|
|
|
‡a
cardiacejectionfractionphantomstudycomparingcinemrimagingradionuclidebloodpoolimagingandventriculography
‡A
Cardiac ejection fraction: phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography
‡9
1
|
919
|
|
|
‡a
cardiacphantomevaluationofsimultaneouslyacquireddualisotoperestthallium201stresstechnetium99mspectimages
‡A
Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images
‡9
1
|
919
|
|
|
‡a
cardiovascularandbehavioraleffectsofaerobicexercisetraininginhealthyoldermenandwomen
‡A
Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women
‡9
1
|
919
|
|
|
‡a
celltherapyinmurineatherosclerosisinvivoimagingwithhighresolutionhelicalspect
‡A
Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT.
‡9
1
|
919
|
|
|
‡a
cerebellaractivityanddisturbedtimesenseafterthc
‡A
Cerebellar activity and disturbed time sense after THC.
‡9
1
|
919
|
|
|
‡a
cerebralimagingofdecompressioninjurypatientswith18f2fluoro2deoxyglucosepositronemissiontomography
‡A
Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography.
‡9
1
|
919
|
|
|
‡a
cerebralpetwithflorbetapircomparedwithneuropathologyatautopsyfordetectionofneuriticamyloidβplaquesaprospectivecohortstudy
‡A
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
‡9
1
|
919
|
|
|
‡a
changesinplasmavolumeassociatedwithmentalstressischemiainpatientswithcoronaryarterydisease
‡A
Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease.
‡9
1
|
919
|
|
|
‡a
chroniccsfleakintotheperitonealcavityshownbyradionuclidecisternographysuccessfultreatmentwithanepiduralbloodpatch
‡A
Chronic CSF leak into the peritoneal cavity shown by radionuclide cisternography. Successful treatment with an epidural blood patch.
‡9
1
|
919
|
|
|
‡a
chronicstableanginamonotherapynifedipineversuspropranolol
‡A
Chronic stable angina monotherapy. Nifedipine versus propranolol
‡9
1
|
919
|
|
|
‡a
cisternographicimagingpatternseffectsofpartialextraarachnoidradiopharmaceuticalinjectionandpostinjectioncsfleakage
‡A
Cisternographic imaging patterns: effects of partial extra-arachnoid radiopharmaceutical injection and postinjection CSF leakage
‡9
1
|
919
|
|
|
‡a
clinicalapplicationofpetfortheevaluationofbraintumors
‡A
Clinical application of PET for the evaluation of brain tumors
‡9
1
|
919
|
|
|
‡a
clinicalapplicationsofpetinoncology
‡A
Clinical applications of PET in oncology
‡9
1
|
919
|
|
|
‡a
clinicalexperiencewithalphaparticleemitting211attreatmentofrecurrentbraintumorpatientswith211atlabeledchimericantitenascinmonoclonalantibody81c6
‡A
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
‡9
1
|
919
|
|
|
‡a
clinicaloncologicpositronemissiontomographyanintroduction
‡A
Clinical oncologic positron emission tomography: an introduction
‡9
1
|
919
|
|
|
‡a
clinicalpositronemissiontomographyimaging
‡A
Clinical positron emission tomography imaging
‡9
1
|
919
|
|
|
‡a
clinicalstage1nonsmallcelllungcancerincludingfdgpetimagingsitesandtimetorecurrence
‡A
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence
‡9
1
|
919
|
|
|
‡a
clinicalutilityofapatientspecificalgorithmforsimulatingintracerebraldruginfusions
‡A
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
‡9
1
|
919
|
|
|
‡a
clinicalutilityofpositronemissiontomographyinthediagnosisandmanagementofperiampullaryneoplasms
‡A
Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms
‡9
1
|
919
|
|
|
‡a
combinationofconvergingcollimatorsforhighsensitivitybrainspect
‡A
Combination of converging collimators for high-sensitivity brain SPECT.
‡9
1
|
919
|
|
|
‡a
combinedexerciseradionuclideangiocardiographyandsinglephotonemissioncomputedtomographyperfusionstudiesforassessmentofcoronaryarterydisease
‡A
Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease
‡9
1
|
919
|
|
|
‡a
combinedtc99msestamibi1passradionuclideangiographyandcardiacspectimagingduringarbutamineinfusiondeliveredbyacomputerizedclosedloopsystem
‡A
Combined Tc-99m sestamibi first-pass radionuclide angiography and cardiac SPECT imaging during arbutamine infusion delivered by a computerized closed-loop system
‡9
1
|
919
|
|
|
‡a
comparisonofhipdmandiodoantipyrineinquantifyingregionalcerebralbloodflowinrats
‡A
Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats
‡9
1
|
919
|
|
|
‡a
comparisonoffluorocholineandfluorodeoxyglucoseforpositronemissiontomographyofandrogendependentandandrogenindependentprostatecancer
‡A
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
‡9
1
|
919
|
|
|
‡a
selectiveanddividedvisualattentionagerelatedchangesinregionalcerebralbloodflowmeasuredbyh215opet
‡A
Selective and divided visual attention: age-related changes in regional cerebral blood flow measured by H2(15)O PET
‡9
1
|
919
|
|
|
‡a
comparisonof180degreesand360degreesdatacollectioninthallium201imagingusingsinglephotonemissioncomputerizedtomographyspectconcisecommunication
‡A
Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication
‡9
1
|
919
|
|
|
‡a
comparisonofhighdoseandmediumdosepropranololinthereliefofexerciseinducedmyocardialischemia
‡A
Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia
‡9
1
|
919
|
|
|
‡a
screeningforcerebralmetastaseswithfdgpetinpatientsundergoingwholebodystagingofnoncentralnervoussystemmalignancy
‡A
Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy
‡9
1
|
919
|
|
|
‡a
comparisonofnifedipinealonewithpropranololaloneforstableanginapectorisincludinghemodynamicsatrestandduringexercise
‡A
Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise
‡9
1
|
919
|
|
|
‡a
computedtomographyintheevaluationofthyroiddisease
‡A
Computed tomography in the evaluation of thyroid disease
‡9
1
|
919
|
|
|
‡a
scatterdetectioninspectimagingdependenceonsourcedepthenergyandenergywindow
‡A
Scatter detection in SPECT imaging: dependence on source depth, energy, and energy window
‡9
1
|
919
|
|
|
‡a
concurrentpetctwithanintegratedimagingsystemintersocietydialoguefromthejointworkinggroupoftheamericancollegeofradiologythesocietyofnuclearmedicineandthesocietyofcomputedbodytomographyandmagneticresonance
‡A
Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
‡9
1
|
919
|
|
|
‡a
conebeamcollimationforsinglephotonemissioncomputedtomographyanalysissimulationandimagereconstructionusingfilteredbackprojection
‡A
Cone beam collimation for single photon emission computed tomography: analysis, simulation, and image reconstruction using filtered backprojection.
‡9
1
|
919
|
|
|
‡a
salvageradioimmunotherapywithmurineiodine131labeledantitenascinmonoclonalantibody81c6forpatientswithrecurrentprimaryandmetastaticmalignantbraintumorsphase2studyresults
‡A
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
‡9
1
|
919
|
|
|
‡a
convergenceofthemaximumlikelihoodreconstructionalgorithmforemissioncomputedtomography
‡A
Convergence of the maximum likelihood reconstruction algorithm for emission computed tomography.
‡9
1
|
919
|
|
|
‡a
correlationofhippocampalneuronaldensityandfdgpetinmesialtemporallobeepilepsy
‡A
Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy
‡9
1
|
919
|
|
|
‡a
relativeimportanceofelectrodeplacementovernumberofchannelsintransientmyocardialischemiadetectionbyholtermonitoring
‡A
Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring
‡9
1
|
919
|
|
|
‡a
criteriaforterminationofphase2chemotherapyforpatientswithprogressiveorrecurrentbraintumor
‡A
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
‡9
1
|
919
|
|
|
‡a
deconvolutionofcomptonscatterinspect
‡A
Deconvolution of Compton scatter in SPECT.
‡9
1
|
919
|
|
|
‡a
relationshipbetweencancertypeandimpactofpetandpetctonintendedmanagementfindingsofthenationaloncologicpetregistry
‡A
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry
‡9
1
|
919
|
|
|
‡a
deepvenousthrombosisexperiencewithgradientechomrimagingin66patients
‡A
Deep venous thrombosis: experience with gradient-echo MR imaging in 66 patients
‡9
1
|
919
|
|
|
‡a
depressionandincreasedmyocardialischemicactivityinpatientswithischemicheartdisease
‡A
Depression and increased myocardial ischemic activity in patients with ischemic heart disease.
‡9
1
|
919
|
|
|
‡a
relationbetweenmyocardialperfusionandleftventricularfunctionfollowingacutecoronaryocclusiondisproportionateeffectsofanteriorvsinferiorischemia
‡A
Relation between myocardial perfusion and left ventricular function following acute coronary occlusion: disproportionate effects of anterior vs. inferior ischemia
‡9
1
|
919
|
|
|
‡a
detectionofprimaryandrecurrentlungcancerbymeansoff18fluorodeoxyglucosepositronemissiontomography
‡A
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography
‡9
1
|
919
|
|
|
‡a
detectionofprimaryandrecurrentlungcancerbymeansoff18fluorodeoxyglucosepositronemissiontomographyfdgpet
‡A
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
‡9
1
|
919
|
|
|
‡a
relatingradiationinducedregionallunginjurytochangesinpulmonaryfunctiontests
‡A
Relating radiation-induced regional lung injury to changes in pulmonary function tests
‡9
1
|
919
|
|
|
‡a
detectionofprimarybreastcarcinomawithadedicatedlargefieldofviewfdgpetmammographydeviceinitialexperience
‡A
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience
‡9
1
|
919
|
|
|
‡a
detectionofpulmonaryemboliindogscomparisonofsinglephotonemissioncomputedtomographygammacameraimagingandangiography
‡A
Detection of pulmonary emboli in dogs: comparison of single photon emission computed tomography, gamma camera imaging, and angiography
‡9
1
|
919
|
|
|
‡a
regulationofstrokevolumeduringsubmaximalandmaximaluprightexerciseinnormalman
‡A
Regulation of stroke volume during submaximal and maximal upright exercise in normal man
‡9
1
|
919
|
|
|
‡a
determinantsofvariableexerciseperformanceamongpatientswithsevereleftventriculardysfunction
‡A
Determinants of variable exercise performance among patients with severe left ventricular dysfunction.
‡9
1
|
919
|
|
|
‡a
determinationofbothmechanicalandelectronicshiftsinconebeamspect
‡A
Determination of both mechanical and electronic shifts in cone beam SPECT.
‡9
1
|
919
|
|
|
‡a
regionaldoseresponsetopulmonaryirradiationusingamanualmethod
‡A
Regional dose response to pulmonary irradiation using a manual method
‡9
1
|
919
|
|
|
‡a
diagnosisofpancreaticcarcinomaroleoffdgpet
‡A
Diagnosis of pancreatic carcinoma: role of FDG PET
‡9
1
|
919
|
|
|
‡a
differentiatingcerebrallymphomafromnonmalignantcentralnervoussystemlesionsinpatientswithaids
‡A
Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS
‡9
1
|
919
|
|
|
‡a
regionalcerebralbloodflowanddepersonalizationaftertetrahydrocannabinoladministration
‡A
Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration
‡9
1
|
919
|
|
|
‡a
directconebeamspectreconstructionwithcameratilt
‡A
Direct cone beam SPECT reconstruction with camera tilt
‡9
1
|
919
|
|
|
‡a
disproportionateeffectsofregionalhypokinesisonradionuclideejectionfractioncompensationusingattenuationcorrectedventricularvolumes
‡A
Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes
‡9
1
|
919
|
|
|
‡a
distributionanddosimetryof1123labeledmonoclonalantibody81c6inpatientswithanaplasticglioma
‡A
Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma
‡9
1
|
919
|
|
|
‡a
distributionof99tcmsulphurcolloidduringgranulocytecolonystimulatingfactoradministrationinautologousbonemarrowtransplantation
‡A
Distribution of 99Tcm-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation
‡9
1
|
919
|
|
|
‡a
doesthepreparationandutilizationof99mtcsulfurcolloidaffecttheoutcomesofbreastlymphoscintigraphy
‡A
Does the preparation and utilization of 99mTc-sulfur colloid affect the outcomes of breast lymphoscintigraphy?
‡9
1
|
919
|
|
|
‡a
dosimetryanddoseresponserelationshipsinnewlydiagnosedpatientswithmalignantgliomastreatedwithiodine131labeledantitenascinmonoclonalantibody81c6therapy
‡A
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
‡9
1
|
919
|
|
|
‡a
dosimetryandradiographicanalysisof131ilabeledantitenascin81c6murinemonoclonalantibodyinnewlydiagnosedpatientswithmalignantgliomasaphase2study
‡A
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
‡9
1
|
919
|
|
|
‡a
dosimetryof131ilabeled81c6monoclonalantibodyadministeredintosurgicallycreatedresectioncavitiesinpatientswithmalignantbraintumors
‡A
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
‡9
1
|
919
|
|
|
‡a
dynamiccontrastenhancedmrimagingassessmentofvascularizedfreefibulargrafts
‡A
Dynamic contrast-enhanced MR imaging assessment of vascularized free fibular grafts
‡9
1
|
919
|
|
|
‡a
regionalcardiacsympatheticinnervationearlyandlateaftertransmyocardiallaserrevascularization
‡A
Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization
‡9
1
|
919
|
|
|
‡a
regionalbrainactivitycorrelatesofnicotinedependence
‡A
Regional brain activity correlates of nicotine dependence
‡9
1
|
919
|
|
|
‡a
regionalbrainactivationinresponsetorectaldistensioninpatientswithirritablebowelsyndromeandtheeffectofahistoryofabuse
‡A
Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse
‡9
1
|
919
|
|
|
‡a
earlyposttransplantf182fluoro2deoxyglucosepositronemissiontomographydoesnotpredictoutcomeforpatientsundergoingautosctinnonhodgkinandhodgkinlymphoma
‡A
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
‡9
1
|
919
|
|
|
‡a
effectofageontheresponseoftheleftventricularejectionfractiontoexercise
‡A
Effect of age on the response of the left ventricular ejection fraction to exercise
‡9
1
|
919
|
|
|
‡a
effectofiodinationlevelonthepropertiesofradioiodinatedfibrinogen
‡A
Effect of iodination level on the properties of radioiodinated fibrinogen.
‡9
1
|
919
|
|
|
‡a
effectofpartialdecreasesinexerciseworkloadonradionuclideindexesofischemia
‡A
Effect of partial decreases in exercise work load on radionuclide indexes of ischemia
‡9
1
|
919
|
|
|
‡a
effectofratedependentleftbundlebranchblockonglobalandregionalleftventricularfunction
‡A
Effect of rate-dependent left bundle branch block on global and regional left ventricular function
‡9
1
|
919
|
|
|
‡a
effectofregionassignmentonrelativerenalbloodflowestimatesusingradionuclides
‡A
Effect of region assignment on relative renal blood flow estimates using radionuclides
‡9
1
|
919
|
|
|
‡a
effectofregistrationerrorsbetweentransmissionandemissionscansonaspectsystemusingsequentialscanning
‡A
Effect of registration errors between transmission and emission scans on a SPECT system using sequential scanning.
‡9
1
|
919
|
|
|
‡a
effectsofcharacteristic10raysonassayof1123bydosecalibrator
‡A
Effects of characteristic x-rays on assay of I-123 by dose calibrator
‡9
1
|
919
|
|
|
‡a
effectsofexerciseandstressmanagementtrainingonmarkersofcardiovascularriskinpatientswithischemicheartdiseasearandomizedcontrolledtrial
‡A
Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial
‡9
1
|
919
|
|
|
‡a
effectsofexercisetrainingonbonedensityinoldermenandwomen
‡A
Effects of Exercise Training on Bone Density in Older Men and Women
‡9
1
|
919
|
|
|
‡a
effectsofexercisetrainingoncardiorespiratoryfunctioninmenandwomenolderthan60yearsofage
‡A
Effects of exercise training on cardiorespiratory function in men and women older than 60 years of age.
‡9
1
|
919
|
|
|
‡a
effectsofexercisetrainingonventricularfunctioninpatientswithrecentmyocardialinfarction
‡A
Effects of exercise training on ventricular function in patients with recent myocardial infarction
‡9
1
|
919
|
|
|
‡a
effectsofphysicalconditioningonleftventricularejectionfractioninpatientswithcoronaryarterydisease
‡A
Effects of physical conditioning on left ventricular ejection fraction in patients with coronary artery disease
‡9
1
|
919
|
|
|
‡a
effectsofspecificactivityonmeta
‡A
Effects of specific activity on meta-[
‡9
1
|
919
|
|
|
‡a
effectsofspecificactivityonmetaiodobenzylguanidinekineticsinisolatedratheart
‡A
Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart
‡9
1
|
919
|
|
|
‡a
efficacyofskullimaginginroutinebonescanning
‡A
Efficacy of skull imaging in routine bone scanning.
‡9
1
|
919
|
|
|
‡a
efficiencycomparisonbetween99mtctetrofosminand99mtcsestamibimyocardialperfusionstudies
‡A
Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies
‡9
1
|
919
|
|
|
‡a
ejectionfractionresponsetoexerciseinpatientswithchestpaincoronaryarterydiseaseandnormalrestingventricularfunction
‡A
Ejection fraction response to exercise in patients with chest pain, coronary artery disease and normal resting ventricular function
‡9
1
|
919
|
|
|
‡a
emotionalresponsivityandtransientmyocardialischemia
‡A
Emotional responsivity and transient myocardial ischemia
‡9
1
|
919
|
|
|
‡a
energyandspatialdistributionofmultipleordercomptonscatterinspectamontecarloinvestigation
‡A
Energy and spatial distribution of multiple order Compton scatter in SPECT: a Monte Carlo investigation
‡9
1
|
919
|
|
|
‡a
esophagealsourcemeasurementoftc99mattenuationcoefficientsforuseinleftventricularvolumedeterminations
‡A
Esophageal source measurement of Tc-99m attenuation coefficients for use in left ventricular volume determinations
‡9
1
|
919
|
|
|
‡a
estimationofmyocardialbloodflowforlongitudinalstudieswith13nlabeledammoniaandpositronemissiontomography
‡A
Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography
‡9
1
|
919
|
|
|
‡a
evaluationofadrenalmassesinpatientswithbronchogeniccarcinomausing18ffluorodeoxyglucosepositronemissiontomography
‡A
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography
‡9
1
|
919
|
|
|
‡a
evaluationofpatientswithroundatelectasisusing2fluoro2deoxy500glucosepet
‡A
Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET
‡9
1
|
919
|
|
|
‡a
evaluationofprimarypulmonarycarcinoidtumorsusingfdgpet
‡A
Evaluation of primary pulmonary carcinoid tumors using FDG PET
‡9
1
|
919
|
|
|
‡a
evaluationofrevisedcriteriaforventilationperfusionscintigraphyinpatientswithsuspectedpulmonaryembolism
‡A
Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism.
‡9
1
|
919
|
|
|
‡a
evaluationofspectquantificationofradiopharmaceuticaldistributionincaninemyocardium
‡A
Evaluation of SPECT quantification of radiopharmaceutical distribution in canine myocardium.
‡9
1
|
919
|
|
|
‡a
exerciseradionuclideangiocardiographypredictscardiacdeathinpatientswithcoronaryarterydisease
‡A
Exercise radionuclide angiocardiography predicts cardiac death in patients with coronary artery disease
‡9
1
|
919
|
|
|
‡a
experimentallymeasuredscatterfractionsandenergyspectraasatestofmontecarlosimulations
‡A
Experimentally measured scatter fractions and energy spectra as a test of Monte Carlo simulations
‡9
1
|
919
|
|
|
‡a
factorsaffectingventricularvolumesdeterminedbyacountbasedequilibriummethod
‡A
Factors affecting ventricular volumes determined by a count-based equilibrium method.
‡9
1
|
919
|
|
|
‡a
fasttransmissionctfordeterminingattenuationmapsusingacollimatedlinesourcerotatableaircopperleadattenuatorsandfanbeamcollimation
‡A
Fast transmission CT for determining attenuation maps using a collimated line source, rotatable air-copper-lead attenuators and fan-beam collimation
‡9
1
|
919
|
|
|
‡a
fdgimagingoflungnodulesaphantomstudycomparingspectcamerabasedpetanddedicatedpet
‡A
FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET
‡9
1
|
919
|
|
|
‡a
fdgpetimaginginpatientswithpathologicallyverifieddementia
‡A
FDG PET imaging in patients with pathologically verified dementia.
‡9
1
|
919
|
|
|
‡a
fdgpetindifferentiatinglymphomafromnonmalignantcentralnervoussystemlesionsinpatientswithaids
‡A
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
‡9
1
|
919
|
|
|
‡a
fdgpetinpediatricposteriorfossabraintumors
‡A
FDG-PET in Pediatric Posterior Fossa Brain Tumors
‡9
1
|
919
|
|
|
‡a
fdgpetintheselectionofbrainlesionsforbiopsy
‡A
FDG-PET in the selection of brain lesions for biopsy
‡9
1
|
919
|
|
|
‡a
fdgpetofpleuraleffusionsinpatientswithnonsmallcelllungcancer
‡A
FDG PET of pleural effusions in patients with non-small cell lung cancer
‡9
1
|
919
|
|
|
‡a
fibrinogenuptakebythrombieffectofthrombusage
‡A
Fibrinogen uptake by thrombi: effect of thrombus age
‡9
1
|
919
|
|
|
‡a
1inmanevaluationof2highaffinitypsmaavidsmallmoleculesforimagingprostatecancer
‡A
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer
‡9
1
|
919
|
|
|
‡a
fluorine18antimyosinmonoclonalantibodyfragmentspreliminaryinvestigationsinacaninemyocardialinfarctmodel
‡A
Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model
‡9
1
|
919
|
|
|
‡a
focalpulmonaryabnormalitiesevaluationwithf18fluorodeoxyglucosepetscanning
‡A
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
‡9
1
|
919
|
|
|
‡a
fractaltextureanalysisofperfusionlungscans
‡A
Fractal Texture Analysis of Perfusion Lung Scans
‡9
1
|
919
|
|
|
‡a
ga67uptakeinthelunginsarcoidosis
‡A
Ga-67 uptake in the lung in sarcoidosis
‡9
1
|
919
|
|
|
‡a
gallium68labeledredcellsandplateletsnewagentsforpositrontomography
‡A
Gallium-68 labeled red cells and platelets: new agents for positron tomography
‡9
1
|
919
|
|
|
‡a
gangliogliomascharacterizationbyregisteredpositronemissiontomographymrimages
‡A
Gangliogliomas: characterization by registered positron emission tomography-MR images.
‡9
1
|
919
|
|
|
‡a
gated99mtctetrofosminand18ffdgstudiesacomparisonofsingleacquisitionandseparateacquisitionprotocols
‡A
Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.
‡9
1
|
919
|
|
|
‡a
halfconebeamcollimationfortriplecameraspectsystems
‡A
Half-cone beam collimation for triple-camera SPECT systems.
‡9
1
|
919
|
|
|
‡a
headandneckcancerdedicatedfdgpetctprotocolfordetectionphantomandinitialclinicalstudies
‡A
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies
‡9
1
|
919
|
|
|
‡a
highlyiodinatedfibrinogenanewthrombuslocalizingagent
‡A
Highly iodinated fibrinogen: a new thrombus-localizing agent
‡9
1
|
919
|
|
|
‡a
humanherpesvirus6limbicencephalitisafterstemcelltransplantation
‡A
Human herpesvirus 6 limbic encephalitis after stem cell transplantation
‡9
1
|
919
|
|
|
‡a
humanpathologiccorrelationwithpetinischemicandnonischemiccardiomyopathy
‡A
Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy
‡9
1
|
919
|
|
|
‡a
hyperparathyroidisminhighrisksurgicalpatientsevaluationwithdoublephasetechnetium99msestamibiimaging
‡A
Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging
‡9
1
|
919
|
|
|
‡a
identificationofearlyrecurrenceofprimarycentralnervoussystemtumorsbyfluorodeoxyglucosepositronemissiontomography
‡A
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography
‡9
1
|
919
|
|
|
‡a
imageresamplingonacylindricalsectorgrid
‡A
Image resampling on a cylindrical sector grid
‡9
1
|
919
|
|
|
‡a
imagingofpheochromocytomain2dogsusingpfluorobenzylguanidine
‡A
Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine.
‡9
1
|
919
|
|
|
‡a
impactof18ffluoridepetonintendedmanagementofpatientswithcancersotherthanprostatecancerresultsfromthenationaloncologicpetregistry
‡A
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
US
‡9
1
|
996
|
|
|
‡2
ISNI|0000000514390545
|
996
|
|
|
‡2
PTBNP|1604080
|
996
|
|
|
‡2
ISNI|0000000082768849
|
996
|
|
|
‡2
NII|DA06237669
|
996
|
|
|
‡2
LIH|LNB:U3_y_;=B_n_
|
996
|
|
|
‡2
NII|DA10037867
|
996
|
|
|
‡2
LC|n 83128525
|
996
|
|
|
‡2
ISNI|0000000081658170
|
996
|
|
|
‡2
LC|no2011059930
|
996
|
|
|
‡2
LC|no2019181282
|
996
|
|
|
‡2
PLWABN|9810545400805606
|
996
|
|
|
‡2
LC|no2018124467
|
996
|
|
|
‡2
LC|no2022112144
|
996
|
|
|
‡2
NTA|090912187
|
996
|
|
|
‡2
SUDOC|033506299
|
996
|
|
|
‡2
NTA|339645024
|
996
|
|
|
‡2
NUKAT|n 2013180804
|
996
|
|
|
‡2
RERO|A023068437
|
996
|
|
|
‡2
CAOONL|ncf11392280
|
996
|
|
|
‡2
LC|no2018165535
|
996
|
|
|
‡2
SUDOC|115385274
|
996
|
|
|
‡2
LC|no2006133004
|
996
|
|
|
‡2
ISNI|0000000029685681
|
996
|
|
|
‡2
LC|n 83139562
|
996
|
|
|
‡2
LC|n 86829029
|
996
|
|
|
‡2
J9U|987007353218905171
|
996
|
|
|
‡2
ISNI|0000000123281106
|
996
|
|
|
‡2
CAOONL|ncf11613054
|
996
|
|
|
‡2
SUDOC|090223691
|
996
|
|
|
‡2
LC|n 82034583
|
996
|
|
|
‡2
ISNI|0000000053482059
|
996
|
|
|
‡2
LC|no2011133870
|
996
|
|
|
‡2
BNF|14589314
|
996
|
|
|
‡2
ISNI|0000000067429179
|
996
|
|
|
‡2
ISNI|0000000076571214
|
996
|
|
|
‡2
BNF|15589885
|
996
|
|
|
‡2
LC|n 90633097
|
996
|
|
|
‡2
PTBNP|200410
|
996
|
|
|
‡2
NTA|296884820
|
996
|
|
|
‡2
BIBSYS|13034615
|
996
|
|
|
‡2
NII|DA03078467
|
996
|
|
|
‡2
LC|no2024077589
|
996
|
|
|
‡2
LC|no2010097921
|
996
|
|
|
‡2
B2Q|0000490413
|
996
|
|
|
‡2
ISNI|000000045966889X
|
996
|
|
|
‡2
ISNI|0000000366933324
|
996
|
|
|
‡2
CAOONL|ncf10562659
|
996
|
|
|
‡2
SUDOC|137695675
|
996
|
|
|
‡2
SUDOC|19191715X
|
996
|
|
|
‡2
BIBSYS|13033446
|
996
|
|
|
‡2
LC|n 85146805
|
996
|
|
|
‡2
LC|n 2005055774
|
996
|
|
|
‡2
NTA|072044004
|
996
|
|
|
‡2
ISNI|0000000043048953
|
996
|
|
|
‡2
BIBSYS|90980392
|
996
|
|
|
‡2
LC|n 80101543
|
996
|
|
|
‡2
RERO|A010968573
|
996
|
|
|
‡2
LC|no2006061387
|
996
|
|
|
‡2
NUKAT|n 00022570
|
996
|
|
|
‡2
ISNI|0000000045092173
|
996
|
|
|
‡2
LC|no2021152265
|
996
|
|
|
‡2
ISNI|0000000080668959
|
996
|
|
|
‡2
DNB|1071083155
|
996
|
|
|
‡2
ISNI|0000000116296289
|
996
|
|
|
‡2
ISNI|0000000037925120
|
996
|
|
|
‡2
LIH|LNB:B_r__t_P;=CI
|
996
|
|
|
‡2
NII|DA02960478
|
996
|
|
|
‡2
J9U|987007448998805171
|
996
|
|
|
‡2
NDL|00464755
|
996
|
|
|
‡2
LC|n 82076777
|
996
|
|
|
‡2
BNF|17047918
|
996
|
|
|
‡2
RERO|A024776938
|
996
|
|
|
‡2
BIBSYS|8006951
|
996
|
|
|
‡2
BNF|13776014
|
996
|
|
|
‡2
BIBSYS|1025690
|
996
|
|
|
‡2
SUDOC|258117966
|
996
|
|
|
‡2
ISNI|0000000067781615
|
996
|
|
|
‡2
ISNI|000000002951206X
|
996
|
|
|
‡2
SUDOC|169072177
|
996
|
|
|
‡2
PLWABN|9810705569105606
|
996
|
|
|
‡2
LC|n 83074342
|
996
|
|
|
‡2
BNC|981058516834106706
|
996
|
|
|
‡2
LC|no 98047710
|
996
|
|
|
‡2
NUKAT|n 2020147688
|
996
|
|
|
‡2
J9U|987008729498405171
|
996
|
|
|
‡2
LC|n 94099924
|
996
|
|
|
‡2
PLWABN|9810558419505606
|
996
|
|
|
‡2
BIBSYS|90134478
|
996
|
|
|
‡2
LC|no 90000146
|
996
|
|
|
‡2
NUKAT|n 2018125560
|
996
|
|
|
‡2
LC|n 86862919
|
996
|
|
|
‡2
BNF|16187953
|
996
|
|
|
‡2
DNB|1203582692
|
996
|
|
|
‡2
LC|n 89601228
|
996
|
|
|
‡2
ISNI|0000000069610967
|
996
|
|
|
‡2
J9U|987007366380605171
|
996
|
|
|
‡2
LC|n 2002133836
|
996
|
|
|
‡2
BIBSYS|90506627
|
996
|
|
|
‡2
ISNI|0000000383958435
|
996
|
|
|
‡2
SUDOC|166873160
|
996
|
|
|
‡2
DNB|1144505879
|
996
|
|
|
‡2
BNF|12436645
|
996
|
|
|
‡2
BIBSYS|5094656
|
996
|
|
|
‡2
LC|n 84164452
|
996
|
|
|
‡2
J9U|987007450550305171
|
996
|
|
|
‡2
SELIBR|191280
|
996
|
|
|
‡2
NII|DA09053560
|
996
|
|
|
‡2
ISNI|0000000033896991
|
996
|
|
|
‡2
BIBSYS|90300849
|
996
|
|
|
‡2
DNB|1150187557
|
996
|
|
|
‡2
SELIBR|1cr63thpz4l0h242
|
996
|
|
|
‡2
ISNI|0000000042567110
|
996
|
|
|
‡2
BNC|981058609975006706
|
996
|
|
|
‡2
ISNI|0000000066593540
|
996
|
|
|
‡2
ISNI|0000000028543606
|
996
|
|
|
‡2
ISNI|0000000383248740
|
996
|
|
|
‡2
LC|n 80046152
|
996
|
|
|
‡2
LC|n 85328199
|
996
|
|
|
‡2
DNB|1310532591
|
996
|
|
|
‡2
ISNI|0000000030734962
|
996
|
|
|
‡2
NUKAT|n 2009109555
|
996
|
|
|
‡2
ISNI|0000000117889377
|
996
|
|
|
‡2
SUDOC|071844775
|
996
|
|
|
‡2
LC|n 2020047012
|
996
|
|
|
‡2
BNF|13519678
|
996
|
|
|
‡2
DNB|1212790715
|
996
|
|
|
‡2
LC|no2019150184
|
996
|
|
|
‡2
NII|DA1987142X
|
996
|
|
|
‡2
SUDOC|079442765
|
996
|
|
|
‡2
SUDOC|178897132
|
996
|
|
|
‡2
LC|no2024115343
|
996
|
|
|
‡2
BIBSYS|10102815
|
996
|
|
|
‡2
NII|DA14795029
|
996
|
|
|
‡2
LC|n 89143181
|
996
|
|
|
‡2
ISNI|0000000109094064
|
996
|
|
|
‡2
LC|n 98880460
|
996
|
|
|
‡2
DNB|1157293093
|
996
|
|
|
‡2
ISNI|000000002127831X
|
996
|
|
|
‡2
LC|n 2005026679
|
996
|
|
|
‡2
ISNI|0000000384260530
|
996
|
|
|
‡2
RERO|A014236368
|
996
|
|
|
‡2
NUKAT|nx2022584494
|
996
|
|
|
‡2
LC|nb2002064627
|
996
|
|
|
‡2
LC|n 2006073177
|
996
|
|
|
‡2
NTA|072460423
|
996
|
|
|
‡2
LC|n 89117679
|
996
|
|
|
‡2
BNF|12476082
|
996
|
|
|
‡2
SUDOC|241765064
|
996
|
|
|
‡2
BIBSYS|6093250
|
996
|
|
|
‡2
NTA|068545924
|
996
|
|
|
‡2
NSK|000365981
|
996
|
|
|
‡2
N6I|vtls000110905
|
996
|
|
|
‡2
LC|nb2006005926
|
996
|
|
|
‡2
NII|DA0951365X
|
996
|
|
|
‡2
DNB|137129432
|
996
|
|
|
‡2
ISNI|0000000031437644
|
996
|
|
|
‡2
BNF|17754470
|
996
|
|
|
‡2
ISNI|0000000369101590
|
996
|
|
|
‡2
SUDOC|265556120
|
996
|
|
|
‡2
BNF|14561869
|
996
|
|
|
‡2
LC|n 87123344
|
996
|
|
|
‡2
CAOONL|ncf10820909
|
996
|
|
|
‡2
DNB|1020226102
|
996
|
|
|
‡2
CAOONL|ncf10820904
|
996
|
|
|
‡2
ISNI|0000000054942942
|
996
|
|
|
‡2
NKC|jn20011101004
|
996
|
|
|
‡2
LC|n 83066751
|
996
|
|
|
‡2
DNB|1157617867
|
996
|
|
|
‡2
BIBSYS|90266954
|
996
|
|
|
‡2
PLWABN|9814282989805606
|
996
|
|
|
‡2
LC|no2021131600
|
996
|
|
|
‡2
LC|n 89629236
|
996
|
|
|
‡2
SUDOC|204582741
|
996
|
|
|
‡2
DNB|136383297
|
996
|
|
|
‡2
ISNI|0000000065878050
|
996
|
|
|
‡2
ISNI|000000004992976X
|
996
|
|
|
‡2
LC|no2024090536
|
996
|
|
|
‡2
J9U|987007279336905171
|
996
|
|
|
‡2
LC|n 97851772
|
996
|
|
|
‡2
SUDOC|030727049
|
996
|
|
|
‡2
LC|n 97054060
|
996
|
|
|
‡2
LC|no2008043292
|
996
|
|
|
‡2
RERO|A003115649
|
996
|
|
|
‡2
RERO|A003115648
|
996
|
|
|
‡2
NII|DA00704852
|
996
|
|
|
‡2
RERO|A003115646
|
996
|
|
|
‡2
LIH|LNB:C_b__v_W;=CC
|
996
|
|
|
‡2
ISNI|0000000073132160
|
996
|
|
|
‡2
ISNI|0000000077287848
|
996
|
|
|
‡2
ERRR|12627185
|
996
|
|
|
‡2
LC|no2008040926
|
996
|
|
|
‡2
PTBNP|1560100
|
996
|
|
|
‡2
ISNI|0000000116332796
|
996
|
|
|
‡2
LC|n 2023016900
|
996
|
|
|
‡2
B2Q|0000040363
|
996
|
|
|
‡2
DNB|106196437X
|
996
|
|
|
‡2
LC|no 98025152
|
996
|
|
|
‡2
ISNI|0000000040427157
|
996
|
|
|
‡2
NDL|00655659
|
996
|
|
|
‡2
LC|nb2011027591
|
996
|
|
|
‡2
LC|no2006008073
|
996
|
|
|
‡2
LC|n 88191493
|
996
|
|
|
‡2
ICCU|RMRV003847
|
996
|
|
|
‡2
BLBNB|001475008
|
996
|
|
|
‡2
ISNI|0000000052052743
|
996
|
|
|
‡2
CAOONL|ncf11181333
|
996
|
|
|
‡2
RERO|A011141046
|
996
|
|
|
‡2
ISNI|0000000066077167
|
996
|
|
|
‡2
BIBSYS|7061102
|
996
|
|
|
‡2
BIBSYS|6628
|
996
|
|
|
‡2
SUDOC|050217305
|
996
|
|
|
‡2
J9U|987007362264205171
|
996
|
|
|
‡2
CAOONL|ncf11352192
|
996
|
|
|
‡2
ISNI|0000000451344508
|
996
|
|
|
‡2
ISNI|0000000030097684
|
996
|
|
|
‡2
NTA|111000556
|
996
|
|
|
‡2
LC|n 85266235
|
996
|
|
|
‡2
NTA|243332998
|
996
|
|
|
‡2
ISNI|0000000117193759
|
996
|
|
|
‡2
ISNI|0000000032678079
|
996
|
|
|
‡2
BIBSYS|4006785
|
996
|
|
|
‡2
RERO|A021558972
|
996
|
|
|
‡2
LC|n 83068163
|
996
|
|
|
‡2
ISNI|0000000049078627
|
996
|
|
|
‡2
PLWABN|9810583865705606
|
996
|
|
|
‡2
ISNI|0000000082525820
|
996
|
|
|
‡2
LIH|LNB:CT_v__o_;=CM
|
996
|
|
|
‡2
LC|n 2009072895
|
996
|
|
|
‡2
SUDOC|27158386X
|
996
|
|
|
‡2
J9U|987007422412005171
|
996
|
|
|
‡2
ISNI|0000000031492432
|
996
|
|
|
‡2
PLWABN|9810681637505606
|
996
|
|
|
‡2
LC|n 2019060690
|
996
|
|
|
‡2
NUKAT|n 95210366
|
996
|
|
|
‡2
BIBSYS|90363145
|
996
|
|
|
‡2
NII|DA05238214
|
996
|
|
|
‡2
ISNI|000000004026436X
|
996
|
|
|
‡2
NKC|jo20211107147
|
996
|
|
|
‡2
ISNI|0000000049000328
|
996
|
|
|
‡2
ISNI|0000000028655384
|
996
|
|
|
‡2
BNF|12111572
|
996
|
|
|
‡2
LC|no2019101121
|
996
|
|
|
‡2
LC|n 2007183572
|
996
|
|
|
‡2
ISNI|0000000436048751
|
996
|
|
|
‡2
BNF|13775325
|
996
|
|
|
‡2
SUDOC|029501512
|
996
|
|
|
‡2
J9U|987007350545905171
|
996
|
|
|
‡2
CAOONL|ncf11011349
|
996
|
|
|
‡2
NTA|070641501
|
996
|
|
|
‡2
LC|no2005094291
|
997
|
|
|
‡a
1943 2012 lived 0102 0000
‡9
1
|
998
|
|
|
‡a
Coleman, R. Eward
‡q
(Ralph Edward),
‡2
NTA|111000556
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡q
(Ralph Edward),
‡2
NKC|nlk20040151297
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
NUKAT|n 01031710
‡3
title: (0.66, 'petinclinicaloncology', 'clinicalapplicationsofpetinoncology')
‡3
viafid
|
998
|
|
|
‡a
Coleman, R. Edward
‡q
(Ralph Edward),
‡2
LC|n 86040915
‡3
suggested
‡3
partial date, partial title
|
998
|
|
|
‡a
Coleman, Ralph Edward,
‡2
SUDOC|081785968
‡3
suggested
‡3
partial date, partial title
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
BIBSYS|2127530
‡3
suggested
‡3
title: (0.66, 'petinclinicaloncology', 'clinicalapplicationsofpetinoncology')
‡3
viafid
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
NII|DA12718741
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
DNB|136383297
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡q
(Ralph Edward),
‡2
CAOONL|ncf11428710
‡3
partial date, partial title
|
998
|
|
|
‡a
Coleman, R. Edward
‡q
(Ralph Edward),
‡2
J9U|987007430403605171
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Coleman, Ralph Edward
‡2
ISNI|0000000116332796
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Eward
‡2
ISNI|0000000116332796
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
ISNI|0000000116332796
‡3
suggested
|
998
|
|
|
‡a
Coleman, R. Edward
‡2
ISNI|0000000116332796
‡3
suggested
|